Janelidze S, Mattsson N, Palmqvist S, Smith R, Beach TG, Serrano GE, Chai X, Proctor NK, Eichenlaub U, Zetterberg H, Blennow K, Reiman EM, Stomrud E, Dage JL, Hansson O. Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia. Nat Med. 2020 Mar;26(3):379-386. Epub 2020 Mar 2 PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)		 Cohort
(N)		 Measurement
Mean ± SD		 Method;
Assay Name;
Manufacturer		 Diagnostic
Criteria
tau-p181
(Plasma)		 AD
(38)		 4.73 ± 2.04
pg/mL §		 Electrochemiluminescence;
Other/Not Specified;
Meso Scale Discovery
tau-p181
(Plasma)		 CTRL-
CNC
(26)		 1.8 ± 1.23
pg/mL §		 Electrochemiluminescence;
Other/Not Specified;
Meso Scale Discovery

§ Data supplied to Alzforum by author

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. A Phospho-Tau Plasma Assay for Alzheimer’s?
  2. New Assay, New Cohorts—Plasma p-Tau181 Looks Even Better
  3. Plasma Aβ Test Wins Approval—Are p-Tau Tests Far Behind?
  4. Where to Now, Phospho-Tau?

AlzBiomarker

  1. AD vs CTRL : tau-p181 (Plasma and Serum)
  2. CTRL vs AD : tau-p181 (Plasma and Serum)